Today: 21 May 2026
Browse Category

NYSE:UNH 30 December 2025 - 9 January 2026

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth Group shares rose 2% to $348.97 Tuesday after Sky News reported TPG is nearing a deal to buy the insurer’s Optum UK unit for up to £1.4 billion. The report comes weeks before UnitedHealth’s Jan. 27 earnings, where it will give 2026 guidance. Talks remain tentative, with Bank of America advising and other firms interested. Optum UK includes EMIS, acquired for £1.24 billion and cleared by UK regulators in 2023.
Dow Jones today: Record highs hold as investors brace for Friday jobs report

Dow Jones today: Record highs hold as investors brace for Friday jobs report

The Dow Jones Industrial Average rose 0.9% Tuesday, nearing the 50,000 mark, led by gains in UnitedHealth and Amazon. S&P 500 and Nasdaq each added about 0.5%. Traders looked ahead to Friday’s U.S. jobs report for signals on Federal Reserve rate moves. Richmond Fed President Thomas Barkin said future rate changes will depend on incoming data.
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth shares rose 1.7% to $342.02 Monday after Barclays raised its price target to $391 and reaffirmed an Overweight rating. The move came as investors positioned ahead of UnitedHealth’s Jan. 27 earnings and 2026 guidance. The stock traded between $333.86 and $346.83 on volume of 7.9 million shares. UnitedHealth remains well below its 52-week high of $606.36.
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
Dow Jones today: Boeing, Caterpillar power blue-chip rise as jobs report looms

Dow Jones today: Boeing, Caterpillar power blue-chip rise as jobs report looms

The Dow Jones Industrial Average rose 319.10 points, or 0.7%, to 48,382.39 on Friday, while the S&P 500 gained 0.2% and the Nasdaq slipped 0.03%. Industrials led the Dow’s advance, with Caterpillar and Boeing together accounting for over 200 points of the rise. Chip stocks rallied, but Tesla shares fell about 2% after reporting an 8.6% drop in 2025 deliveries. President Trump delayed higher tariffs on some Chinese imports for a year.
UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

UnitedHealth shares closed up 1.9% at $336.40 Friday and rose another 0.2% after hours. Investors await the company’s Jan. 27 report on 2025 results and 2026 guidance, including updates on operational reviews and diagnosis code audits. Managed-care stocks broadly gained as the Dow rose 0.66% on the year’s first trading day. UnitedHealth continues to cooperate with federal probes into its Medicare Advantage billing practices.
1 4 5 6 7 8 10

Stock Market Today

  • Trump Delays AI Executive Order Featuring Voluntary Corporate Participation
    May 21, 2026, 2:21 PM EDT. President Donald Trump postponed the signing of an executive order on artificial intelligence, originally intended to emphasize voluntary participation by companies. Trump cited dissatisfaction with "certain aspects" of the order, leading to the delay announced Thursday. The move pauses anticipated regulatory guidelines aimed at steering AI development through corporate cooperation rather than mandatory controls. This delay adds uncertainty to the administration's approach to AI governance, signaling possible revisions or shifts in policy priorities as the U.S. seeks to balance innovation and oversight in this critical technology sector.

Latest articles

SoFi Stock Treads Water as Traders Keep an Eye on Next Move

SoFi Stock Treads Water as Traders Keep an Eye on Next Move

21 May 2026
SoFi Technologies shares fell 0.2% to $15.66 in early trading Thursday, underperforming tech peers as investors weighed strong first-quarter results against concerns over rates and credit risk. The company reported record loan originations of $12.2 billion and net income of $166.7 million, but kept its 2026 profit outlook unchanged after April’s earnings, disappointing some analysts.
Kraken’s Dubai Approval Gives It a Regulated Shot at UAE Crypto Traders

Kraken’s Dubai Approval Gives It a Regulated Shot at UAE Crypto Traders

21 May 2026
Kraken parent Payward has received preliminary approval from Dubai’s Virtual Assets Regulatory Authority for a broker-dealer and investment licence, moving closer to a UAE launch. The approval allows Kraken to offer dirham funding, spot and margin trading, and institutional services, pending final regulatory clearance. Dubai’s VARA already licenses Binance, OKX, and Crypto.com. Kraken’s Dubai unit will operate under local supervision.
Navitas Jumps Again as Next AI Power Trade Test Hits

Navitas Jumps Again as Next AI Power Trade Test Hits

21 May 2026
Navitas Semiconductor shares jumped 5.3% to $24.20 on Thursday, hitting a new intraday and near 52-week high, with over 22 million shares traded. The move followed news that CEO Chris Allexandre and CFO Tonya Stevens will meet investors at upcoming Craig-Hallum and Evercore conferences. Navitas reported Q1 revenue of $8.6 million, up 18% sequentially but down year-over-year.
Go toTop